Platelet MEKK3 regulates arterial thrombosis and myocardial infarct expansion in mice
Platelet MEKK3 regulates arterial thrombosis and myocardial infarct expansion in mice
复制标题
血小板 MEKK3 调节小鼠动脉血栓形成和心肌梗塞扩张。
DOI:
10.1182/bloodadvances.2017015149
复制
发表时间:
2018-06-26
期刊:
影响因子:
7.5
通讯作者:
Liu, Junling
中科院分区:
文献类型:
--
作者:
Fan, Xuemei;Wang, Conghui;Liu, Junling
MAPKs play important roles in platelet activation. However, the molecular mechanisms by which MAPKs are regulated in platelets remain largely unknown. Real-time polymerase chain reaction and western blot data showed that MEMO, a key MAP3K family member, was expressed in human and mouse platelets. Then, megakaryocyte/platelet-specific MEKK3-deletion (MEKK3(-/-)) mice were developed to elucidate the platelet-related function(s) of MEMO. We found that agonist-induced aggregation and degranulation were reduced in MEKK3(-/-) platelets in vitro. MEMO deficiency significantly impaired integrin alpha IIb beta 3-mediated inside-out signaling but did not affect the outside-in signaling. At the molecular level, MEKK3 deficiency led to severely impaired activation of extracellular signal-regulated kinases 1/2 (ERK1/2) and c-Jun NH2-terminal kinase 2 but not p38 or ERK5. In vivo, MEKK3(-/-) mice showed delayed thrombus formation following FeCl3-induced carotid artery injury. Interestingly, the tail bleeding time was normal in MEKK3(-/-) mice. Moreover, MEKK3(-/-) mice had fewer microthrombi, reduced myocardial infarction (MI) size, and improved post-MI heart function in a mouse model of MI. These results suggest that MEMO plays important roles in platelet MAPK activation and may be used as a new effective target for antithrombosis and prevention of MI expansion.